The expanding demand for controlled immunological study and therapeutic creation has spurred significant advances in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently produced using multiple expression systems, including microbial hosts, mammalian cell populations, and baculoviru